Wide Ranks

FENC

Fennec Pharmaceuticals Inc.

6.01

Top Statistics
Market Cap 165 M Forward PE 34.84 Revenue Growth 7.00 %
Current Ratio 7.80 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -2.30 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue 3.17 Price To Sales Trailing12 Months 3.36
Profitability
Profit Margins -2.30 % Operating Margins -74.59 %
Balance Sheet
Total Cash 40 M Total Cash Per Share 1.47 Total Debt 32 M
Total Debt To Equity Current Ratio 7.80 Book Value Per Share -0.1890
All Measures
Short Ratio 1759.00 % Message Board Id finmb_1455350 Shares Short Prior Month 1 M
City Research Triangle Park Uuid c4d49e37-489f-3603-bf6e-9e09850463da Previous Close 6.04
First Trade Date Epoch Utc 1 B Book Value -0.1890 Beta 0.2670
Total Debt 32 M Volume 305589 Fifty Two Week Low 3.96
Total Cash Per Share 1.47 Total Revenue 49 M Shares Short Previous Month Date 1 B
Target Median Price 13.00 Max Age 86400 Recommendation Mean 1.40
Sand P52 Week Change 0.3133 Operating Margins -74.59 % Target Mean Price 13.60
Net Income To Common -1133000 Short Percent Of Float 0.0992 Implied Shares Outstanding 27 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 207020
Average Volume10days 207020 Total Cash 40 M Next Fiscal Year End 1 B
Revenue Per Share 1.81 Held Percent Insiders 0.1622 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 6.04
Target Low Price 12.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 4.69
Open 6.01 Free Cashflow -3402500 State NC
Dividend Yield 0.00 % Return On Assets 0.0270 Time Zone Short Name EST
Trailing Eps -0.0400 Day Low 6.00 Address1 68 TW Alexander Drive
Shares Outstanding 27 M Price Hint 2 Target High Price 15.00
Website https://www.fennecpharma.com 52 Week Change -0.3012 Average Volume 109093
Forward Eps 0.3700 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 715.90 % Is_sp_500 False Regular Market Day High 6.55
Profit Margins -2.30 % Fifty Two Week High 11.92 Day High 6.55
Shares Short 1 M Regular Market Open 6.01 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 3.17 Revenue Growth 7.00 %
Shares Percent Shares Out 0.0680 Operating Cashflow 23 M Currency USD
Time Zone Full Name America/New_York Market Cap 165 M Is_nasdaq_100 False
Zip 27709 Quote Type EQUITY Industry Biotechnology
Long Name Fennec Pharmaceuticals Inc. Regular Market Day Low 6.00 Held Percent Institutions 0.5473
Current Price 6.01 Address2 PO Box 13628 Financial Currency USD
Current Ratio 7.80 Gross Margins 93.51 % Industry Disp Biotechnology
Number Of Analyst Opinions 5 Country United States Float Shares 14 M
Two Hundred Day Average 6.97 Enterprise Value 156 M Price To Sales Trailing12 Months 3.36
Forward PE 34.84 Regular Market Volume 305589 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States.

The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients.

It sells its products through regional pediatric oncology specialists and medical science liaisons.

The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014.

Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.